{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:49:51Z","timestamp":1792633791093,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673813"],"award-info":[{"award-number":["81673813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biopha.2020.110381","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T06:30:35Z","timestamp":1593844235000},"page":"110381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress"],"prefix":"10.1016","volume":"129","author":[{"given":"Yi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110381_bib0005","first-page":"1","article-title":"Cancer statistics: updated cancer burden in China","volume":"27","author":"Chen","year":"2015","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110381_bib0010","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.3748\/wjg.v25.i20.2489","article-title":"Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations","volume":"25","author":"Jiang","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2020.110381_bib0015","article-title":"Cancer-targeted PEDF-DNA therapy for metastatic colorectal cancer","author":"Bao","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2020.110381_bib0020","doi-asserted-by":"crossref","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biopha.2020.110381_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical pharmacology of 5-fluorouracil","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2020.110381_bib0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1078-0432.CCR-0913-3","article-title":"Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts","volume":"10","author":"Azrak","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110381_bib0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/CAD.0b013e3282ff0f48","article-title":"Systemic nonhormonal management of advanced prostate cancer and its likely impact on patients\u2019 survival and quality of life","volume":"19","author":"Azim","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2020.110381_bib0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12253-013-9695-0","article-title":"Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer","volume":"20","author":"Manoochehri","year":"2014","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biopha.2020.110381_bib0045","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1016\/j.dnarep.2015.12.003","article-title":"A history of the DNA repair and mutagenesis field: the discovery of base excision repair","volume":"37","author":"Friedberg","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.biopha.2020.110381_bib0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12885-019-5438-2","article-title":"Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort","volume":"19","author":"Sone","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2020.110381_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00726-010-0522-6","article-title":"Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy","volume":"41","author":"Melino","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.biopha.2020.110381_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5507\/bp.2008.007","article-title":"Expression of multidrug resistance-related protein (MRP-1), lung resistance-related protein (LRP) and topoisomerase-II (TOPO-II) in Wilms\u2019 tumor: immunohistochemical study using TMA methodology","volume":"152","author":"Fridman","year":"2008","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.biopha.2020.110381_bib0065","doi-asserted-by":"crossref","first-page":"12793","DOI":"10.18632\/aging.102603","article-title":"Loss of Klotho contributes to cartilage damage by derepression of canonical Wnt\/beta-catenin signaling in osteoarthritis mice","volume":"11","author":"Gu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2020.110381_bib0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.yexcr.2017.07.025","article-title":"Frizzled-7 mediates TGF-beta-induced pulmonary fibrosis by transmitting non-canonical Wnt signaling","volume":"359","author":"Guan","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2020.110381_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110381_bib0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature14897","article-title":"Distinct EMT programs control normal mammary stem cells and tumour-initiating cells","volume":"525","author":"Ye","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110381_bib0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/np500762w","article-title":"Jalapinoside, a macrocyclic bisdesmoside from the resin glycosides of Ipomea purga, as a modulator of multidrug resistance in human cancer cells","volume":"78","author":"Bautista","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2020.110381_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12154-015-0144-2","article-title":"Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells","volume":"9","author":"Esmaeili","year":"2016","journal-title":"J. Chem. Biol."},{"key":"10.1016\/j.biopha.2020.110381_bib0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2407-10-219","article-title":"Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin","volume":"10","author":"Xiong","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2020.110381_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/ph13010002","article-title":"Dextran-curcumin nanoparticles as a methotrexate delivery vehicle: a step forward in breast cancer combination therapy","volume":"13","author":"Curcio","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.biopha.2020.110381_bib0105","first-page":"2943","article-title":"Downregulation of glucose-regulated protein 78 enhances the cytotoxic effects of curcumin on human nasopharyngeal carcinoma cells","volume":"42","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2020.110381_bib0110","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.2147\/DDDT.S210949","article-title":"Delivery of curcumin nanoliposomes using surface modified with CD133 aptamers for prostate cancer","volume":"13","author":"Ma","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2020.110381_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117044","article-title":"Curcumin potentiates the galbanic acid-induced anti-tumor effect in non-small cell lung cancer cells through inhibiting Akt\/mTOR signaling pathway","volume":"239","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2020.110381_bib0120","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7469284","article-title":"Erratum to \u201csynergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells\u201d","volume":"2019","author":"Parasramka","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.biopha.2020.110381_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2018.05.036","article-title":"Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1","volume":"431","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2020.110381_bib0130","first-page":"1343","article-title":"Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells","volume":"53","author":"Su","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2020.110381_bib0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11655-018-2997-z","article-title":"Curcumin reverses 5-Fluorouracil resistance by promoting human colon cancer hct-8\/5-FU cell apoptosis and down-regulating heat shock protein 27 and P-Glycoprotein","volume":"25","author":"He","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.biopha.2020.110381_bib0140","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3892\/or.2016.4669","article-title":"Curcumin inhibits tumor epithelialmesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2020.110381_bib0145","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1128\/MCB.19.10.6690","article-title":"Roles of cell division and gene transcription in the methylation of CpG islands","volume":"19","author":"Bender","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2020.110381_bib0150","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2020.110381_bib0155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/bjc.2015.480","article-title":"Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer","volume":"114","author":"Elez","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2020.110381_bib0160","first-page":"10564","article-title":"Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism","volume":"23","author":"Mani","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110381_bib0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/carcin\/bgr016","article-title":"COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63\/73 in colorectal cancer","volume":"32","author":"Sui","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2020.110381_bib0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cas.13833","article-title":"Nuclear factor I\/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance","volume":"110","author":"Liu","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2020.110381_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101658","article-title":"Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance","volume":"8","author":"Teeuwssen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2020.110381_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1242\/jcs.120907","article-title":"Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis","volume":"126","author":"Frisch","year":"2013","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2020.110381_bib0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cellsig.2013.11.032","article-title":"Wnt signaling in adult intestinal stem cells and cancer","volume":"26","author":"Krausova","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2020.110381_bib0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.humpath.2017.09.016","article-title":"Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma","volume":"72","author":"Wang","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.biopha.2020.110381_bib0195","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7150\/jca.16914","article-title":"Epigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia","volume":"8","author":"Li","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2020.110381_bib0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI71605","article-title":"Cancer epigenetics drug discovery and development: the challenge of hitting the mark","volume":"124","author":"Campbell","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110381_bib0205","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature12750","article-title":"TET enzymes, TDG and the dynamics of DNA demethylation","volume":"502","author":"Kohli","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110381_bib0210","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1038\/onc.2014.356","article-title":"TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway","volume":"34","author":"Neri","year":"2015","journal-title":"Oncogene"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:14:44Z","timestamp":1760098484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220305746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S0753332220305746"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110381","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110381"}}